M Masi

778 total citations
26 papers, 597 citations indexed

About

M Masi is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, M Masi has authored 26 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in M Masi's work include Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). M Masi is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). M Masi collaborates with scholars based in Italy. M Masi's co-authors include Roberto Stasi, Giovanni Del Poeta, Adriano Venditti, Antonio Bruno, Germano Aronica, Maria Christina Cox, Sergio Amadori, M Tribalto, Elisa Stipa and Francesco Buccisano and has published in prestigious journals such as Blood, Animals and Annals of Hematology.

In The Last Decade

M Masi

26 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Masi Italy 13 458 218 130 129 105 26 597
Jolanta B. Perz Germany 14 396 0.9× 402 1.8× 191 1.5× 154 1.2× 154 1.5× 27 795
Hyeoung Joon Kim South Korea 11 263 0.6× 118 0.5× 46 0.4× 79 0.6× 145 1.4× 57 471
D. Urbanitz Germany 8 458 1.0× 161 0.7× 291 2.2× 148 1.1× 83 0.8× 41 665
Angeline Van Orshoven Belgium 15 488 1.1× 183 0.8× 152 1.2× 75 0.6× 291 2.8× 29 735
A Granda Spain 9 397 0.9× 98 0.4× 39 0.3× 159 1.2× 113 1.1× 11 447
Salvatore Palmieri Italy 16 687 1.5× 262 1.2× 171 1.3× 214 1.7× 148 1.4× 47 815
Ali Tabarroki United States 10 448 1.0× 348 1.6× 44 0.3× 60 0.5× 225 2.1× 27 679
Martine Guesnu France 16 589 1.3× 296 1.4× 89 0.7× 48 0.4× 224 2.1× 24 736
S Gentili Italy 10 399 0.9× 154 0.7× 33 0.3× 139 1.1× 345 3.3× 16 685
J O Moore United States 9 436 1.0× 148 0.7× 169 1.3× 102 0.8× 126 1.2× 9 600

Countries citing papers authored by M Masi

Since Specialization
Citations

This map shows the geographic impact of M Masi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Masi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Masi more than expected).

Fields of papers citing papers by M Masi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Masi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Masi. The network helps show where M Masi may publish in the future.

Co-authorship network of co-authors of M Masi

This figure shows the co-authorship network connecting the top 25 collaborators of M Masi. A scholar is included among the top collaborators of M Masi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Masi. M Masi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fabritiis, Paolo de, T Dentamaro, Alessandra Picardi, et al.. (2004). Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.. PubMed. 89(2). 243–5. 18 indexed citations
3.
Venditti, Adriano, Anna Tamburini, Francesco Buccisano, et al.. (2000). A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes. Annals of Hematology. 79(3). 138–142. 24 indexed citations
4.
Venditti, Adriano, Giovanni Del Poeta, Francesco Buccisano, et al.. (1998). Biological Features of Acute Myeloid Leukemia in the Elderly. Blood. 92(2). 697–699. 15 indexed citations
5.
Amadori, Sergio, Adriano Venditti, Giovanni Del Poeta, et al.. (1996). Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis. Annals of Hematology. 72(4). 208–215. 22 indexed citations
6.
Maffei, Laura, Maria Cantonetti, Giovanni Del Poeta, et al.. (1996). FISH analysis for CML monitoring ?. Annals of Hematology. 73(3). 113–119. 21 indexed citations
7.
Poeta, Giovanni Del, Roberto Stasi, Germano Aronica, et al.. (1996). Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood. 87(5). 1997–2004. 6 indexed citations
8.
Poeta, Giovanni Del, Roberto Stasi, Germano Aronica, et al.. (1996). Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood. 87(5). 1997–2004. 113 indexed citations
9.
Sciarra, Alessandro, Roberto Stasi, Elisa Stipa, et al.. (1995). [Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma].. PubMed. 86(2). 57–62. 11 indexed citations
10.
Stasi, Roberto, Giovanni Del Poeta, Adriano Venditti, et al.. (1994). Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0). Blood. 83(6). 1619–1625. 67 indexed citations
11.
Stasi, Roberto, Elisa Stipa, M Masi, et al.. (1994). Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood. 84(12). 4203–4208. 113 indexed citations
12.
Tovo, Pier‐Angelo, et al.. (1993). [The use of thymopentin in the prevention of recurrent infections of the respiratory system. Multicenter study].. PubMed. 45(12). 505–10. 3 indexed citations
13.
Poeta, Giovanni Del, Roberto Stasi, Adriano Venditti, M Masi, & Giuseppe Papa. (1993). CD7 expression in acute myeloid leukemia [letter; comment] [see comments]. Blood. 82(9). 2929–2930. 4 indexed citations
14.
Venditti, Adriano, Roberto Stasi, M Masi, et al.. (1993). All-trans retinoic acid plus low doses of cytarabine for the treatment of “poor-risk” acute myeloid leukemias. Annals of Hematology. 66(2). 59–60. 7 indexed citations
15.
Franchi, A., Giuseppe Francesco Sferrazza Papa, Stefania D’Atri, et al.. (1992). Cytotoxic effects of dacarbazine in patients with acute myelogenous leukemia: a pilot study.. PubMed. 77(2). 146–50. 18 indexed citations
16.
Adorno, Gaspare, A. Bruno, M Masi, et al.. (1992). Anti-D treatment in thrombocytopenia refractory to conventional therapies.. PubMed. 77(1). 97–8. 2 indexed citations
17.
Tribalto, M, Maria Cantonetti, Gianfranco Catalano, et al.. (1992). Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients.. PubMed. 76(5). 402–5. 2 indexed citations
18.
Cudillo, Laura, Maria Cantonetti, Adriano Venditti, et al.. (1991). Peripheral polyneuropathy during treatment with alpha-2 interferon.. PubMed. 75(5). 485–6. 12 indexed citations
19.
Antimi, Mauro, M Masi, André Delannoy, et al.. (1991). The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation.. PubMed. 75(5). 443–6. 1 indexed citations
20.
Masi, M, et al.. (1981). Effects of asphyxia and oral gentamicin on intestinal lactase in the suckling rat.. PubMed. 1(3). 215–20. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026